Helle Størum

Nessuna posizione attualmente

57 anni

Health Technology

Finance

Consumer Services

Profilo

Helle Størum worked as a Principal at H.
Lundbeck A from 2007 to 2016.
She then worked as a Director of Business Development at Zealand Pharma A from 2016 to 2017, and at Pharmacosmos A from 2017 to 2020.
She also worked as a Principal at Takeda A.
Currently, she is the Head of Business Development at Amniotics AB since 2020.
Ms. Størum holds a Master's degree in Business Administration from the University of Southern Denmark.

Precedenti posizioni note di Helle Størum

Società	Posizione	Fine
AMNIOTICS AB	Corporate Officer/Principal	01/12/2023
Pharmacosmos A/S Pharmacosmos A/S Pharmaceuticals: MajorHealth Technology Pharmacosmos A/S develops treatments of iron deficiency anemia in humans and animals. Its products include monofer, cosmofer, diafer and uniferon. The company was founded by Dr. Henry M. Christensen in 1965 and is headquartered in Holbæk, Denmark.	Corporate Officer/Principal	01/01/2020
ZEALAND PHARMA A/S	Direttore/Membro del Consiglio	19/04/2016
H. LUNDBECK A/S	Corporate Officer/Principal	01/03/2016
Takeda A/S Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Helle Størum

Formazione di Helle Størum

University of Southern Denmark

Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Helle Størum

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	3
H. LUNDBECK A/S	Health Technology
ZEALAND PHARMA A/S	Health Technology
AMNIOTICS AB	Health Technology

Aziende private	2
Takeda A/S Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark.	Finance
Pharmacosmos A/S Pharmacosmos A/S Pharmaceuticals: MajorHealth Technology Pharmacosmos A/S develops treatments of iron deficiency anemia in humans and animals. Its products include monofer, cosmofer, diafer and uniferon. The company was founded by Dr. Henry M. Christensen in 1965 and is headquartered in Holbæk, Denmark.	Health Technology

Vedi le connessioni aziendali

Borsa valori
Insiders
Helle Størum